---
title: "ESC 2025: AQUATIC trial cautions against use of aspirin in chronic coronary syndrome patients receiving anticoagulation"
date: "2025-09-04T08:25:20.000Z"
publishedDate: "4 septembre 2025"
summary: "New evidence cautions against the use of aspirin in patients with chronic coronary syndrome who have had prior stenting and require long-term oral anticoagulation. Investigators in the AQUATIC trial, a double-blind placebo-controlled trial in chronic coronary syndrome patients after stenting receiving long-term oral anticoagulants conducted at more than 50 centres in France, found that the [&#8230;] The post ESC 2025: AQUATIC trial cautions against use of aspirin in chronic coronary syndrome patients receiving anticoagulation appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/esc-2025-aquatic-trial-cautions-against-use-of-aspirin-in-chronic-coronary-syndrome-patients-receiving-anticoagulation/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-09-04-esc-2025-aquatic-trial-cautions-against-use-of-aspirin-in-chronic-coronary-syndrome-patients-receiving-anticoagulation"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/09/IMG_5176-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/esc-2025-aquatic-trial-cautions-against-use-of-aspirin-in-chronic-coronary-syndrome-patients-receiving-anticoagulation/"
---

![ESC 2025: AQUATIC trial cautions against use of aspirin in chronic coronary syndrome patients receiving anticoagulation](http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/09/IMG_5176-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/esc-2025-aquatic-trial-cautions-against-use-of-aspirin-in-chronic-coronary-syndrome-patients-receiving-anticoagulation/*

## L’essentiel

New evidence cautions against the use of aspirin in patients with chronic coronary syndrome who have had prior stenting and require long-term oral anticoagulation. Investigators in the AQUATIC trial, a double-blind placebo-controlled trial in chronic coronary syndrome patients after stenting receiving long-term oral anticoagulants conducted at more than 50 centres in France, found that the [&#8230;] The post ESC 2025: AQUATIC trial cautions against use of aspirin in chronic coronary syndrome patients receiving anticoagulation appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/esc-2025-aquatic-trial-cautions-against-use-of-aspirin-in-chronic-coronary-syndrome-patients-receiving-anticoagulation/
